Oracle Corporation Japan announced that ONO PHARMACEUTICAL CO., LTD. implemented Oracle’s Clinical Trial Management System (CTMS) Cloud Service as an IT platform for clinical trials as part of ONO’s digital transformation (DX) strategy.

The implementation of this system enables the centralized management of clinical trial information and monitoring activities globally and is expected to significantly reduce the system management workload compared to before implementation.

Under the corporate philosophy of “Dedicated to the Fight against Disease and Pain,” ONO aims to implement corporate transformation in the digital and IT fields, including renovating its IT infrastructure with an eye toward globalization and transformation of the drug discovery value chain, and achieving sustainable growth by promoting innovation and creating innovative new drugs.

The IT infrastructure of drug development plays an important role in promoting business efficiency and supplying the most consistent and up-to-date data in the DX strategy. Clinical trials continue to diversify, and the number of large-scale global clinical trials is expected to further increase in the future. Under such circumstances, there is a need to manage monitoring activities and clinical trial information in a more timely and efficient manner. Oracle’s CTMS can help improve the quality and efficiency of clinical trials by managing the progress of global clinical trials and integrating with other existing systems, and it can utilize data stored in internal systems to predict potential risks and improve the probability of trial success.